Online Exclusives

Online Exclusives

MSKCC Researchers Correct Financial Disclosures

After reports from ProPublica and The New York Times revealed that scientists from Memorial Sloan Kettering Cancer Center (MSKCC) failed to disclose financial relationships...

Congress Passes Bills Banning Gag Clauses

Congress has passed two bills to ban “gag clauses” in contracts between pharmacies and insurance companies or pharmacy benefit managers (PBMs). The legislation, supported...

Justice Department Approves CVS-Aetna Merger

The U.S. Department of Justice (DOJ) has approved the merger of the pharmacy and health-care provider CVS Health with insurer Aetna, which would create...

FDA Approves DNA-Based Blood Compatibility Test

The U.S. Food and Drug Administration (FDA) has approved ID CORE XT, a molecular-based assay that can be used to determine blood donor and...

Clinical Trials of Leukemia and Lymphoma Drug Placed on Hold

Pharmaceutical manufacturer Affimed has halted two trials of its CD19/CD3-targeting T-cell engager AFM11 following reports of three serious adverse events (AEs), including one patient...

FDA Panel Recommends Rituximab Biosimilar for Lymphoma

The U.S. Food and Drug Administration’s (FDA’s) Oncologic Drugs Advisory Committee (ODAC) unanimously voted to recommend approval for CT-P10, a biosimilar of rituximab. The...

AMA Announces “Reimagined” Medical Education

The American Medical Association (AMA) has announced the next phase of its Accelerating Change in Medical Education program, which is designed to create training...

Patient Dies After Developing Resistance to CAR T-Cell Therapy

A young patient with B-cell acute lymphocytic leukemia who received chimeric antigen receptor (CAR) T-cell therapy developed a resistance to his treatment, according to...

Revamped NAFTA Deal Criticized for Drug Price Provisions

The recently updated North American Free Trade Agreement, now known as the U.S.-Mexico-Canada Agreement (USMCA), includes a 10-year exclusivity period for biologics. While the...

FDA Approves New Hemophilia A Drug

The U.S. Food and Drug Administration (FDA) has approved emicizumab-kxwh for the treatment of adult and pediatric patients with hemophilia A without factor VIII...
Advertisement

Current Issue

October 2018, Volume 4, Issue 12

This issue features a look at the Right to Try debate, a breakdown of how epigenetics are used in hematology, and more.